Lunai Bioworks Inc. Amortization of Intangible Assets
Lunai Bioworks Inc. (LNAI) reported Amortization of Intangible Assets of $9.90 thousand for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2025-09-29
- Lunai Bioworks Inc. amortization of intangible assets for the quarter ending 2024-06-30 was $772.00, a 51.84% decline year-over-year.
- Lunai Bioworks Inc. amortization of intangible assets for the quarter ending 2024-03-31 was $779.00, a 50.70% decline year-over-year.
- Lunai Bioworks Inc. amortization of intangible assets for the quarter ending 2023-12-31 was $5.96K, a 295.75% increase year-over-year.
- Lunai Bioworks Inc. amortization of intangible assets for the quarter ending 2023-09-30 was $781.00, a 47.44% decline year-over-year.
- Lunai Bioworks Inc. amortization of intangible assets for fiscal 2025 was $9.90K, a 19.36% increase from fiscal 2024.
- Lunai Bioworks Inc. amortization of intangible assets for fiscal 2024 was $8.30K, a 34.35% increase from fiscal 2023.
- Lunai Bioworks Inc. amortization of intangible assets for fiscal 2023 was $6.17K, a 58.82% decline from fiscal 2022.
- Lunai Bioworks Inc. amortization of intangible assets for fiscal 2022 was $14.99K, a 5.62% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | $9.90K 10-K · filed 2025-09-29 | ||||
| 2024-06-30 | $772.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-29 | $1.55K derived: sum of 2 quarters · filed 2025-09-29 | $7.51K derived: sum of 3 quarters · filed 2025-09-29 | $8.30K 10-K · filed 2025-09-29 | |
| 2024-03-31 | $779.00 10-Q/A · filed 2025-02-19 | $6.74K derived: sum of 2 quarters · filed 2025-02-19 | $7.52K 10-Q/A · filed 2025-02-19 | $9.13K derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-12-31 | $5.96K 10-Q · filed 2024-02-14 | $6.75K 10-Q · filed 2024-02-14 | $8.35K derived: sum of 3 quarters · filed 2025-02-19 | $9.93K derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-09-30 | $781.00 10-Q · filed 2023-11-14 | $2.38K derived: sum of 2 quarters · filed 2025-02-19 | $3.96K derived: sum of 3 quarters · filed 2025-02-19 | $5.47K derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-06-30 | $1.60K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-02-19 | $3.18K derived: sum of 2 quarters · filed 2025-02-19 | $4.69K derived: sum of 3 quarters · filed 2025-02-19 | $6.17K 10-K/A · filed 2025-02-19 | |
| 2023-03-31 | $1.58K 10-Q/A · filed 2025-02-19 | $3.09K derived: sum of 2 quarters · filed 2025-02-19 | $4.57K 10-Q/A · filed 2025-02-19 | $8.10K derived: sum of 4 quarters · filed 2025-02-19 | |
| 2022-12-31 | $1.51K 10-Q · filed 2024-02-14 | $2.99K 10-Q · filed 2024-02-14 | $6.52K derived: sum of 3 quarters · filed 2024-02-14 | $10.25K derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $1.49K 10-Q · filed 2023-11-14 | $5.01K derived: sum of 2 quarters · filed 2023-11-14 | $8.74K derived: sum of 3 quarters · filed 2023-11-14 | $12.55K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $3.52K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-02 | $7.25K derived: sum of 2 quarters · filed 2023-10-02 | $11.07K derived: sum of 3 quarters · filed 2023-10-02 | $14.99K 10-K · filed 2023-10-02 | |
| 2022-03-31 | $3.73K 10-Q · filed 2023-05-12 | $7.54K derived: sum of 2 quarters · filed 2023-05-12 | $11.47K 10-Q · filed 2023-05-12 | $15.49K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $3.81K 10-Q · filed 2023-03-09 | $7.74K 10-Q · filed 2023-03-09 | $11.76K derived: sum of 3 quarters · filed 2023-03-09 | $15.77K derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-09-30 | $3.93K 10-Q · filed 2023-03-07 | $7.94K derived: sum of 2 quarters · filed 2023-03-07 | $11.96K derived: sum of 3 quarters · filed 2023-03-07 | $15.90K derived: sum of 4 quarters · filed 2023-03-07 | |
| 2021-06-30 | $4.02K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $8.03K derived: sum of 2 quarters · filed 2023-02-27 | $11.98K derived: sum of 3 quarters · filed 2023-02-27 | $15.89K 10-K · filed 2023-02-27 | |
| 2021-03-31 | $4.01K 10-Q · filed 2022-05-13 | $7.96K derived: sum of 2 quarters · filed 2022-05-13 | $11.87K 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | $3.95K 10-Q · filed 2022-02-14 | $7.86K 10-Q · filed 2022-02-14 | |||
| 2020-09-30 | $3.91K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $14.77K 10-K · filed 2021-09-24 | $14.72K 10-K · filed 2020-09-23 | |||
| 2019-09-30 | $15.15K 10-Q · filed 2019-11-13 | -$5.78M derived: sum of 2 quarters · filed 2020-09-23 | -$1.92M derived: sum of 3 quarters · filed 2020-09-23 | ||
| 2019-06-30 | -$5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | -$1.94M derived: sum of 2 quarters · filed 2020-09-23 | $15.15K 10-K · filed 2020-09-23 | ||
| 2019-03-31 | $3.86M 10-Q · filed 2019-05-16 | $5.81M 10-Q · filed 2019-05-16 | |||
| 2018-06-30 | $18.48K 10-K · filed 2019-09-30 | $3.04M 10-K · filed 2018-10-01 | |||
| 2017-06-30 | $19.78K 10-K · filed 2018-10-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |